Ocular Therapeutix
OCUL
OCUL
65 hedge funds and large institutions have $140M invested in Ocular Therapeutix in 2018 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 25 increasing their positions, 13 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
65
Holders Change
-4
Holders Change %
-5.8%
% of All Funds
1.49%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
7
Increased
25
Reduced
13
Closed
11
Calls
$1.29M
Puts
$622K
Net Calls
+$670K
Net Calls Change
+$726K
Top Buyers
| 1 |
SR
Summer Road
West Palm Beach,
Florida
|
+$19.7M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$13.5M |
| 3 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$7.23M |
| 4 |
DAM
Deltec Asset Management
New York
|
+$2.42M |
| 5 |
Jennison Associates
New York
|
+$1.94M |
Top Sellers
| 1 |
VF
Virtu Financial
New York
|
-$279K |
| 2 |
D.E. Shaw & Co
New York
|
-$267K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$219K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$216K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$177K |